TrialRMD open2023

Sustained remission following the discontinuation of tofacitinib in patients with rheumatoid arthritis (XANADU study): an open-label randomised study.

Satoshi Kubo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.